"10.1371_journal.pone.0101777","plos one","2014-08-01T00:00:00Z","Angel E Dago; Asya Stepansky; Anders Carlsson; Madelyn Luttgen; Jude Kendall; Timour Baslan; Anand Kolatkar; Michael Wigler; Kelly Bethel; Mitchell E Gross; James Hicks; Peter Kuhn","Department of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America; Skyline Genomics, Roslyn Heights, New York, United States of America; Department of Molecular and Cellular Biology, Stony Brook University, Stony Brook, New York, United States of America; Department of Pathology, Scripps Clinic, La Jolla, California, United States of America; Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California, United States of America","Conceived and designed the experiments: AED MEG JH PK. Performed the experiments: AED AS. Analyzed the data: AED AC MEG JK JH PK. Contributed reagents/materials/analysis tools: AS AC ML JK AK TB MW KB. Wrote the paper: AED AC MEG JH PK.","The authors have read the journal's policy and have conflicts to disclose. The HD-CTC assay technology described here has been licensed to Epic Sciences. ML, AK, KB and PK have ownership interests in Epic Sciences. AS is an employee of Skyline Genomics, and had a significant role in developing the protocol for isolating DNA from HD-CTC cells and performed the Illumina library preparations. AS did not have any role in design of the experiments or interpretation of the data. JH is a co-founder and shareholder in skyline genomics. AED, AC, JK, TB, MW and MEG and have declared that no competing interests exist.","2014","08","Angel E Dago","AED",12,FALSE,4,2,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
